Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Gut Microbiota and Metabolic Specificity in Ulcerative Colitis and Crohn's Disease
Jagadesan Sankarasubramanian, Rizwan Ahmad, Nagavardhini Avuthu, et al.
Frontiers in Medicine (2020) Vol. 7
Open Access | Times Cited: 83

Showing 1-25 of 83 citing articles:

Two-Sample Mendelian Randomization Analysis Investigates Causal Associations Between Gut Microbial Genera and Inflammatory Bowel Disease, and Specificity Causal Associations in Ulcerative Colitis or Crohn’s Disease
Bin Liu, Ding Ye, Hong Yang, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 105
Composition and diverse differences of intestinal microbiota in ulcerative colitis patients
Siying Zhu, Muzhou Han, Simao Liu, et al.
Frontiers in Cellular and Infection Microbiology (2022) Vol. 12
Open Access | Times Cited: 64
Unraveling the Impact of Gut and Oral Microbiome on Gut Health in Inflammatory Bowel Diseases
Hala Elzayat, Ghaidaa Mesto, Farah Al‐Marzooq
Nutrients (2023) Vol. 15, Iss. 15, pp. 3377-3377
Open Access | Times Cited: 31
Mucosal healing and inflammatory bowel disease: Therapeutic implications and new targets
Megan Lynn Otte, Raju Lama Tamang, Julia Papapanagiotou, et al.
World Journal of Gastroenterology (2023) Vol. 29, Iss. 7, pp. 1157-1172
Open Access | Times Cited: 28
Exploring the Gut Microbiome’s Role in Inflammatory Bowel Disease: Insights and Interventions
Despoina Gyriki, Christos Nikolaidis, Elisavet Stavropoulou, et al.
Journal of Personalized Medicine (2024) Vol. 14, Iss. 5, pp. 507-507
Open Access | Times Cited: 8
Long‐Term Risk of Inflammatory Bowel Disease With MASLD: A Large‐Scale Prospective Cohort Study in UK Biobank
Qian Zhang, Fang Xu, Zuyao Wang, et al.
Journal of Gastroenterology and Hepatology (2025)
Closed Access | Times Cited: 1
MicroRNA and Gut Microbiota: Tiny but Mighty—Novel Insights into Their Cross-talk in Inflammatory Bowel Disease Pathogenesis and Therapeutics
Maite Casado‐Bedmar, Émilie Viennois
Journal of Crohn s and Colitis (2021) Vol. 16, Iss. 6, pp. 992-1005
Open Access | Times Cited: 51
Molecular and Pathophysiological Links between Metabolic Disorders and Inflammatory Bowel Diseases
Chang‐Kee Hyun
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 17, pp. 9139-9139
Open Access | Times Cited: 46
Amelioration of AOM/DSS-Induced Murine Colitis-Associated Cancer by Evodiamine Intervention is Primarily Associated with Gut Microbiota-Metabolism-Inflammatory Signaling Axis
Mengxia Wang, Biqiang Zhou, Weihong Cong, et al.
Frontiers in Pharmacology (2021) Vol. 12
Open Access | Times Cited: 43
FODMAPs, inflammatory bowel disease and gut microbiota: updated overview on the current evidence
Catarina Simões, Marta Gabriela Rilho Maganinho, Ana S. Sousa
European Journal of Nutrition (2022) Vol. 61, Iss. 3, pp. 1187-1198
Closed Access | Times Cited: 33
Probiotic-Based Intervention in the Treatment of Ulcerative Colitis: Conventional and New Approaches
Jana Štofilová, Monika Kvaková, Anna Kamlárová, et al.
Biomedicines (2022) Vol. 10, Iss. 9, pp. 2236-2236
Open Access | Times Cited: 31
A Novel Probiotic Combination Ameliorates Crohn’s Disease–Like Ileitis by Increasing Short-Chain Fatty Acid Production and Modulating Essential Adaptive Immune Pathways
Luca Di Martino, Abdullah Ösme, Mahmoud A. Ghannoum, et al.
Inflammatory Bowel Diseases (2023) Vol. 29, Iss. 7, pp. 1105-1117
Open Access | Times Cited: 22
tRNA queuosine modification is involved in biofilm formation and virulence in bacteria
Jorge Díaz-Rullo, José Eduardo González‐Pastor
Nucleic Acids Research (2023) Vol. 51, Iss. 18, pp. 9821-9837
Open Access | Times Cited: 22
Gut microbiota signatures in inflammatory bowel disease
Marie Vibeke Vestergaard, Kristine H. Allin, Carsten Eriksen, et al.
United European Gastroenterology Journal (2023) Vol. 12, Iss. 1, pp. 22-33
Open Access | Times Cited: 18
Integrative analysis of single-cell RNA-seq and gut microbiome metabarcoding data elucidates macrophage dysfunction in mice with DSS-induced ulcerative colitis
Dawon Hong, Hyo Keun Kim, Wonhee Yang, et al.
Communications Biology (2024) Vol. 7, Iss. 1
Open Access | Times Cited: 7
Evaluation of gut microbiota predictive potential associated with phenotypic characteristics to identify multifactorial diseases
D.C. Fonseca, Ilanna Marques Gomes da Rocha, Bianca Depieri Balmant, et al.
Gut Microbes (2024) Vol. 16, Iss. 1
Open Access | Times Cited: 6
Crosstalk Between Intestinal Serotonergic System and Pattern Recognition Receptors on the Microbiota–Gut–Brain Axis
Elena Layunta, Berta Buey, José Emilio Mesonero, et al.
Frontiers in Endocrinology (2021) Vol. 12
Open Access | Times Cited: 34
The role of gut microbiome in inflammatory bowel disease diagnosis and prognosis
Jiaying Zheng, Qianru Sun, Jingwan Zhang, et al.
United European Gastroenterology Journal (2022) Vol. 10, Iss. 10, pp. 1091-1102
Open Access | Times Cited: 26
Causal association between common rheumatic diseases and glaucoma: a Mendelian randomization study
Yang Meng, Zongbiao Tan, Yu Su, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 14
Colorectal cancer and Blastocystis sp. infection
Violetta Sulżyc‐Bielicka, Lidia Kołodziejczyk, Małgorzata Adamska, et al.
Parasites & Vectors (2021) Vol. 14, Iss. 1
Open Access | Times Cited: 31
Identification of causal metabolites related to multiple autoimmune diseases
Xinghao Yu, Rong‐Rong Cao, Yiqun Yang, et al.
Human Molecular Genetics (2021) Vol. 31, Iss. 4, pp. 604-613
Closed Access | Times Cited: 28
Kui Jie Tong Ameliorates Ulcerative Colitis by Regulating Gut Microbiota and NLRP3/Caspase-1 Classical Pyroptosis Signaling Pathway
Shigui Xue, Yan Xue, Danbo Dou, et al.
Disease Markers (2022) Vol. 2022, pp. 1-15
Open Access | Times Cited: 20
A Matching Strategy To Guide Donor Selection for Ulcerative Colitis in Fecal Microbiota Transplantation: Meta-Analysis and Analytic Hierarchy Process
Bangzhou Zhang, Luxi Yang, Hanbing Ning, et al.
Microbiology Spectrum (2022) Vol. 11, Iss. 1
Open Access | Times Cited: 20
Association between Inflammatory Bowel Disease and Iridocyclitis: A Mendelian Randomization Study
Yang Meng, Zongbiao Tan, Chuan Liu, et al.
Journal of Clinical Medicine (2023) Vol. 12, Iss. 4, pp. 1282-1282
Open Access | Times Cited: 12
Comparative analysis of Parkinson’s and inflammatory bowel disease gut microbiomes reveals shared butyrate-producing bacteria depletion
Maeve E. Krueger, Jake Boles, Zachary D. Simon, et al.
npj Parkinson s Disease (2025) Vol. 11, Iss. 1
Open Access
Page 1 - Next Page

Scroll to top